Hong et al. founded that RUNX1 reduces breast cancer cell migration and invasion in vitro and tumor growth in vivo, and also founded that high levels of RUNX1 expression can suppress metastasis, treatment resistance, and tumor recurrence in breast cancer (Hong et al., 2018). Here, RUNX1 is linked to neoplasm.